Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

538
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
538
Subviral Agents01:29

Subviral Agents

556
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
556
Air-entraining Agents01:27

Air-entraining Agents

268
Air-entraining agents improve the durability and workability of concrete in climates with frequent freezing and thawing. These agents prevent cracks by introducing small air bubbles into the mix, creating spaces accommodating water expansion when temperatures drop. The air-entraining agents lower the surface tension of water, forming stable, small air bubbles. This method is more effective than having accidental large voids, as the intentional, smaller, and evenly distributed air voids improve...
268
Masking and Demasking Agents01:19

Masking and Demasking Agents

3.6K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
3.6K
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

643
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
643

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between hypertension phenotypes and aortic valve peak velocity: a potential tool for identifying white-coat hypertension.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same author

Pleiotropic effects of renal denervation beyond blood pressure reduction.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same author

Single Interventions (Pharmacological or Renal Denervation) Are Not Sufficient to Achieve Blood Pressure Control in Resistant Hypertension a Systematic Review and Meta-Analysis.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Imaging Naxos disease and related cardiocutaneous syndromes: the NAXCARE multimodality approach.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2026
Same author

Aortic stenosis and sleep disordered breathing: The effects of interventional management.

Science progress·2026
Same author

Favorable Effects of Renal Denervation in Hypertension-Related Comorbidities. A Systematic Review and Meta-Analysis.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

Related Experiment Video

Updated: Jan 28, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.0K

Future Anti-aldosterone Agents.

Kyriakos Dimitriadis1, Constantinos Tsioufis1, Panayotis Iliakis1

  • 1First Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece.

Current Pharmaceutical Design
|February 26, 2019
PubMed
Summary

New nonsteroidal mineralocorticoid receptor antagonists, like finerenone, show promise for blood pressure control and organ protection in conditions such as diabetes and heart failure. Further research is needed to fully understand their potential benefits.

Keywords:
Mineralcorticoid receptor antagonistsaldosterone synthase inhibitorsdiabetic nephropathyfinerenoneheart failurehyperkalemia.

More Related Videos

Using Generative Art to Convey Past and Future Climate Transitions
06:10

Using Generative Art to Convey Past and Future Climate Transitions

Published on: March 31, 2023

1.5K
A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents
06:43

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents

Published on: August 31, 2013

19.1K

Related Experiment Videos

Last Updated: Jan 28, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.0K
Using Generative Art to Convey Past and Future Climate Transitions
06:10

Using Generative Art to Convey Past and Future Climate Transitions

Published on: March 31, 2023

1.5K
A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents
06:43

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents

Published on: August 31, 2013

19.1K

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Endocrinology

Background:

  • The renin-angiotensin-aldosterone system is crucial for managing blood pressure and protecting the kidneys and heart.
  • Targeting this axis offers significant therapeutic potential for cardiovascular and renal diseases.

Purpose of the Study:

  • To review novel nonsteroidal mineralocorticoid receptor antagonists.
  • To focus on finerenone and aldosterone synthase inhibitors.
  • To discuss their clinical applications and future directions.

Main Methods:

  • A comprehensive literature review was conducted.
  • The review focused on narrative synthesis of existing research.
  • Key randomized controlled trials were analyzed.

Main Results:

  • Nonsteroidal mineralocorticoid receptor antagonists, particularly finerenone, are safe and effective treatments.
  • Finerenone demonstrates efficacy in diabetes mellitus, chronic kidney disease, and heart failure.
  • Aldosterone synthase inhibitors present potential but have limitations in duration and side effects.

Conclusions:

  • Third-generation nonsteroidal mineralocorticoid receptor antagonists offer significant advantages.
  • Wider clinical use of mineralocorticoid receptor antagonists is anticipated.
  • Future randomized controlled trials are essential to confirm long-term benefits and safety.